Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01480440 · ClinicalTrials.gov registry record

Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System

A clinical trial of Rheumatoid Arthritis and Osteoarthritis, sponsored by Zimmer Biomet.

Active
Registry status
200
Enrollment target
5
Study locations

NCT01480440 is a study of Rheumatoid Arthritis and Osteoarthritis that is active but no longer recruiting, run by Zimmer Biomet. The registered enrollment target is 200 participants, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The trial reports 5 study locations across 5 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01480440, a study of Rheumatoid Arthritis and Osteoarthritis, is active but no longer recruiting, sponsored by Zimmer Biomet.

ACTIVE NOT RECRUITING
Registry status
200 participants
Enrollment target
5
Study locations

Study Summary

The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.

Interventions

  • DEVICE Trabecular Metal Reverse Shoulder System

Study Locations (5)

California

  • University of California, San Francisco - San Francisco

Kentucky

  • Norton Orthopaedic & Sports Medicine - Louisville

New Jersey

  • The Rothman Institute - Egg Harbor

Pennsylvania

  • The Rothman Institute - Philadelphia

Lancashire

  • Royal Blackburn Hospital - Blackburn

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2011-01
Est. Completion 2026-12

Sponsor

Zimmer Biomet

115 total trials

What the Registry Record Tells You About NCT01480440

The ClinicalTrials.gov registry entry for NCT01480440 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,690-participant average among 197 other Rheumatoid Arthritis trials with a reported enrollment target (96% lower). The listed sponsor is Zimmer Biomet, which has 115 total studies on file at ClinicalTrials.gov.

The record links to 8 conditions, with Rheumatoid Arthritis appearing as the primary indexed condition, and to 1 intervention - of which Trabecular Metal Reverse Shoulder System is the first listed.

NCT01480440 reports 5 study locations spanning 5 distinct geographic areas - top geographies include California, Kentucky, New Jersey.

Frequently Asked Questions

What is clinical trial NCT01480440 about?

NCT01480440 is a clinical study titled "Outcomes Study of the Trabecular Metal (TM) Reverse Shoulder System". The objectives of this study are to obtain survival and outcome data on the Trabecular Metal Reverse Shoulder System when used in primary or revision reverse total shoulder arthroplasty.

What is the current status of trial NCT01480440?

This trial is currently active not recruiting. The enrollment target is 200 participants. The study started on 2011-01. Estimated completion is 2026-12.

What conditions does trial NCT01480440 study?

This clinical trial studies the following conditions: Rheumatoid Arthritis, Osteoarthritis, Avascular Necrosis, Post Traumatic Arthritis, Ununited Humeral Head Fracture.

What interventions are being tested in trial NCT01480440?

The interventions under investigation include: Trabecular Metal Reverse Shoulder System (DEVICE).

Who is sponsoring clinical trial NCT01480440?

This trial is sponsored by Zimmer Biomet, which has 115 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01480440 being conducted?

This trial has 5 study locations across California, Kentucky, New Jersey, Pennsylvania, Lancashire. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Rheumatoid Arthritis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.